Britannia Life Sciences Inc.
BLSIF
$0.0666
-$0.0114-14.62%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 4.50M | 5.46M | 688.30K | 723.30K | 542.40K |
Total Receivables | 147.80K | 158.70K | 792.10K | 1.24M | 1.12M |
Inventory | -- | -- | 135.00K | 144.20K | 136.20K |
Prepaid Expenses | 9.40K | 17.00K | 13.30K | 20.30K | 25.30K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 1.32M | 1.27M | -- | -- | -- |
Total Current Assets | 5.98M | 6.91M | 1.63M | 2.13M | 1.83M |
|
|||||
Total Current Assets | 5.98M | 6.91M | 1.63M | 2.13M | 1.83M |
Net Property, Plant & Equipment | 93.90K | 99.50K | 427.40K | 489.50K | 497.10K |
Long-term Investments | -- | -- | 13.02M | 13.91M | 13.13M |
Goodwill | -- | -- | 13.02M | 13.91M | 13.13M |
Total Other Intangibles | -- | -- | 330.90K | 321.40K | 264.40K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 7.19M | 8.08M | 15.41M | 16.84M | 15.88M |
|
|||||
Total Accounts Payable | 1.04M | 1.54M | 1.51M | 2.05M | 2.10M |
Total Accrued Expenses | 751.30K | 863.00K | 1.02M | 541.30K | 275.80K |
Short-term Debt | 21.70K | 20.40K | 19.80K | 21.10K | 107.60K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 125.20K | 119.60K | 1.69M | 1.74M | 1.59M |
Total Finance Division Other Current Liabilities | -- | -- | 3.86M | 4.12M | 3.90M |
Total Other Current Liabilities | -- | -- | 3.86M | 4.12M | 3.90M |
Total Current Liabilities | 1.94M | 2.54M | 8.10M | 8.48M | 7.97M |
|
|||||
Total Current Liabilities | 1.94M | 2.54M | 8.10M | 8.48M | 7.97M |
Long-Term Debt | 1.12M | 1.07M | 3.07M | 3.54M | 3.13M |
Short-term Debt | 21.70K | 20.40K | 19.80K | 21.10K | 107.60K |
Capital Leases | 69.50K | 79.60K | 164.30K | 195.90K | 203.50K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | 21.50K | 22.90K | 21.70K |
Total Liabilities | 3.13M | 3.69M | 11.35M | 12.24M | 11.33M |
|
|||||
Common Stock & APIC | 15.04M | 14.27M | 14.26M | 15.19M | 14.99M |
Retained Earnings | -10.25M | -9.25M | -13.51M | -14.28M | -13.20M |
Treasury Stock & Other | -725.90K | -644.80K | 68.50K | 220.70K | -393.30K |
Total Common Equity | 4.07M | 4.38M | 821.40K | 1.12M | 1.39M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 4.07M | 4.38M | 821.40K | 1.12M | 1.39M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | 3.23M | 3.48M | 3.16M |
Total Equity | 4.07M | 4.38M | 4.06M | 4.60M | 4.55M |
|